Participants in this activity will learn how CMS measures medication adherence, its role in patient qualification status, impact on claims algorithms, and potential caveats of these determinations. Strategies to address common barriers to medication adherence will be discussed, along with best practices that may improve adherence. In addition, the five measures included in the 2021 Medicare Part D star ratings, including those regarding medication adherence for diabetes, hypertension, cholesterol, as well as statin use in persons with diabetes, will be reviewed.

This activity will assist learners in identifying optimal lifestyle and behavioral changes that can impact disease development and progression in their patients and will discuss practical strategies and forms of support that HCPs can offer to assist patients in setting healthy lifestyle goals. Learners will examine how appropriate prescribing decisions must be based on a comparative analysis of diabetes medications and will also review disease etiology and biological changes seen during disease progression. Lastly, the presenter will discuss policy and system changes that can best assist in integrating evidence into daily practice for the purpose of maximizing health in individuals with T2D. 

This activity will explore the current and future application of gene therapy.

This activity will explore the recent advances in BMT, including in-home stem-cell treatments outside the hospital setting and their clinical outcomes, as well as the challenges and impact COVID-19 has had on immunosuppressed individuals and BMT.